7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Li G et al. | Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. | 2015 | Int J Clin Exp Pathol | pmid:26884838 |
| Li B et al. | Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. | 2015 | Genet. Mol. Res. | pmid:26782591 |
| Mrozikiewicz-Rakowska B et al. | Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. | 2015 | J. Physiol. Pharmacol. | pmid:26579581 |
| Kurz K et al. | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. | 2015 | Dis. Markers | pmid:26576067 |
| Liu W et al. | Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. | 2015 | PLoS ONE | pmid:26571489 |
| Schiro A et al. | Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. | 2015 | Sci Rep | pmid:26564003 |
| Mizuno M et al. | Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. | 2015 | Sci Rep | pmid:26561427 |
| Morisawa T et al. | Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. | 2015 | Int Heart J | pmid:26549398 |
| Beuselinck B et al. | RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. | 2015 | Br. J. Cancer | pmid:26528707 |
| Rewiuk K and Grodzicki T | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. | 2015 | Biomed Res Int | pmid:26504794 |
| Pesce Viglietti AI et al. | Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. | 2015 | Infect. Immun. | pmid:26459511 |
| Nemeth ZK et al. | Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. | 2015 | Sci Rep | pmid:26459001 |
| Grosjean F et al. | Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. | 2015 | PLoS ONE | pmid:26247358 |
| Lewis JR et al. | Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. | 2015 | PLoS ONE | pmid:26222774 |
| Audo R et al. | Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. | 2015 | Arthritis Res. Ther. | pmid:26220665 |
| Wang J et al. | RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. | 2015 | PLoS ONE | pmid:26218592 |
| Kao SY and Stankovic KM | Transactivation of human osteoprotegerin promoter by GATA-3. | 2015 | Sci Rep | pmid:26216189 |
| Kassem A et al. | TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. | 2015 | FASEB J. | pmid:26207027 |
| Yang H et al. | A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. | 2015 | Int J Clin Exp Pathol | pmid:26191212 |
| Pitari MR et al. | Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. | 2015 | Oncotarget | pmid:26160841 |
| Hsu BG et al. | High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. | 2015 | Tohoku J. Exp. Med. | pmid:26156285 |
| Miao X et al. | Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. | 2015 | J Orthop Surg Res | pmid:26148858 |
| Bartosińska J et al. | The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. | 2015 | Mediators Inflamm. | pmid:26146462 |
| Ye XH et al. | Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. | 2015 | Genet. Mol. Res. | pmid:26125863 |
| Ye M et al. | Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. | 2015 | Mol Med Rep | pmid:26459042 |
| Priyadarshi S et al. | Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. | 2015 | Ann. Hum. Genet. | pmid:25998045 |
| Yang Y et al. | The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. | 2015 | J. Biol. Chem. | pmid:25979341 |
| Ehlken C et al. | Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. | 2015 | PLoS ONE | pmid:25978399 |
| Ardeshirpour L et al. | OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. | 2015 | Endocrinology | pmid:25961842 |
| Reveille JD | Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. | 2015 | Clin. Rheumatol. | pmid:25939520 |
| Bortolin RH et al. | Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. | 2015 | PLoS ONE | pmid:25933189 |
| Wei J et al. | Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. | 2015 | Mol Med Rep | pmid:25891179 |
| Su F et al. | Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. | 2015 | Stem Cell Res Ther | pmid:25888745 |
| Shen Y et al. | (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. | 2015 | BMC Complement Altern Med | pmid:25887296 |
| Duan P et al. | Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. | 2015 | BMC Womens Health | pmid:25884698 |
| Warren JT et al. | Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. | 2015 | J. Cell. Biochem. | pmid:25864714 |
| Kim KR et al. | 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. | 2015 | PLoS ONE | pmid:25859665 |
| HaDuong JH et al. | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. | 2015 | Int. J. Cancer | pmid:25648303 |
| Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
| Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
| Dale MD et al. | Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. | 2015 | Int J Mol Sci | pmid:25625518 |
| Ottewell PD et al. | OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. | 2015 | Int. J. Cancer | pmid:25603921 |
| Son GY et al. | Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. | 2015 | J. Dent. Res. | pmid:25595364 |
| Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |
| Majerczyk M et al. | [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. | 2015 | Postepy Hig Med Dosw (Online) | pmid:27259222 |
| Fu Y et al. | Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. | 2015 | J. Vet. Sci. | pmid:25549213 |
| Recker EN et al. | A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. | 2015 | J. Periodontol. | pmid:25269523 |
| Hung JY et al. | Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. | 2015 | Int. J. Oncol. | pmid:25738754 |
| Nash LA et al. | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. | 2015 | Mol Nutr Food Res | pmid:25488131 |
| Jin Y et al. | Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. | 2015 | Angle Orthod | pmid:24810489 |